Why the study?
Does aspirin prevent acute myocardial infarction in primary and secondary prevention settings?
Population
Patients at risk for primary or secondary acute myocardial infarction
Design
Review
Authors
Loading...
Aspirin benefit for MI prevention remains uncertain; leaves open the need for definitive trials weighing hemorrhage risk.
Does aspirin prevent acute myocardial infarction in primary and secondary prevention settings?
The efficacy of aspirin in preventing primary or secondary myocardial infarction remains unclear, and its use must be weighed against the risk of hemorrhage and should not substitute for risk factor modification.
Lekstrom et al. (1991) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: